Business Environment

October 10, 2025 | Business Environment

US Healthcare Providers, Payers Boost AI Investments to Drive Profitability: Bain & KLAS Study

US healthcare providers and payers are ramping up the AI investments most likely to improve profit margins as they focus on an imperative of harnessing tech to bolster returns, a new study from Bain & Company and KLAS Research reveals. The prioritization of technology solutions that deliver greatest impact to bottom lines comes as the healthcare sector's deployment of AI moves from a previous phase of broad exploration to focused execution to capture financial benefits, Bain and KLAS report in their 2025 Healthcare IT Spending study. 70% of providers and 80% of payers now have an AI strategy in place or in development – significantly up from 60% for both groups in last year's Bain/KLAS survey. The 2025 Bain/KLAS survey of some 228 US healthcare provider and payer executives finds that revenue cycle management (RCM) and clinical workflow are providers' key priorities while payers emphasize utilization and network management. Providers remain capacity-constrained, prioritizing solutions with demonstrable return on investment (ROI). Payers face higher medical loss ratios, utilization rates, and risk-adjustment scrutiny while they brace for enrollment pressures. "Healthcare AI is moving out of the pilot stage and being leveraged to meet profitability needs of both providers and payers," said Aaron Feinberg, partner in Bain & Company's Healthcare & Life Sciences and Private Equity practice. "Executives want quickly scalable solutions that address key business challenges and pay for themselves with tangible results and short time-to-value windows. This is all about the bottom line now." "AI in healthcare is here to stay, and providers and payers are wisely moving from exploration to execution," said Adam Gale, CEO of KLAS Research. "While results are encouraging, it will take time to fully understand the financial impact. What's clear is the strong intent to scale thoughtfully—focusing on use cases that improve experiences for patients, members, and clinicians."

October 08, 2025 | Business Environment

CVS Health Launches Workforce Innovation and Talent Center in Fort Worth

CVS Health is expanding access to health care careers with the launch of its new Workforce Innovation and Talent Center and Community Resource Center in Fort Worth, in collaboration with Fort Worth Housing Solutions. The new dynamic space is designed to build a pipeline of skilled health care professionals by offering no-cost workforce training and health care services. "Our new Workforce Innovation and Talent Center aims to create pathways to opportunity," said Sheryl Burke, SVP of Corporate Social Responsibility and Chief Sustainability Officer at CVS Health. "By working hand-in-hand with the Fort Worth Housing Solutions and local workforce organizations, we're helping community members gain the skills they need for in-demand roles—like pharmacy technicians—and build healthier futures for themselves and their families." As the health care industry faces a growing talent shortage, CVS Health is setting a new standard in corporate-led workforce development with its Fort Worth Workforce Innovation and Talent Center. The center offers no-cost, hands-on training for roles like pharmacy technicians, customer service associate and call center representatives for both retail and non-retail —all in a simulated retail environment that mirrors real-world scenarios. Graduates are encouraged to apply for positions at CVS Health, creating a pathway to employment opportunities. "We are so honored to partner with CVS Health in Stop Six," said Mary-Margaret Lemons, President of Fort Worth Housing Solutions. "Over half a billion dollars will be invested in housing and community redevelopment in this neighborhood, and a key part of that strategy is ensuring the people of Stop Six, have access to health care, education and economic mobility. Free training opportunities at the WITC will provide new skills for residents to qualify for higher-paying jobs and change the trajectory of their families. FWHS is so excited to continue this community-building work with CVS Health." Additionally, the WITC will connect participants with valuable resources to aid their success, including Goodwill, Easter Seals and United Way. Participants can also advance their careers through programming pipelines at the College of Healthcare Professions and the University of North Texas. "This partnership between CVS Health and Fort Worth Housing Solutions is exactly the kind of investment that strengthens our city's foundation," said Fort Worth Mayor Mattie Parker. "By equipping residents with skills for high-demand health care jobs and connecting this community with vital resources, the new Workforce Innovation and Talent Center is building a healthier, more prosperous Fort Worth for generations to come." The new Community Resource Center is supported by Aetna, a CVS Health company. The CRC provides the public, including workforce program participants, with access to health education, assistance navigating health benefits, computers and state-of-the-art teleconferencing and available space for community events. Providing visitors with access to health screenings is planned for late 2025. "As a company focused on health solutions, we recognize the connection between stable employment and health and wellness," said Stephanie Rogers, CEO of Aetna Better Health of Texas. "By co-locating the WITC and CRC in Fort Worth, we're bringing together essential resources to help individuals in local communities achieve professional success and lead healthier lives."

October 06, 2025 | Business Environment

Mindcore Technologies Highlights Need for Secure Workspaces in Sensitive Industries

Mindcore Technologies, a leader in IT and cybersecurity services, is emphasizing the growing importance of secure workspace solutions for industries that handle highly sensitive data, including healthcare, finance, legal, retail, and technology.As businesses expand across remote and hybrid work models, many organizations face challenges in safeguarding data, ensuring compliance, and maintaining operational efficiency. Secure workspace platforms address these issues by providing controlled, virtual environments where employees, contractors, and vendors can access files, applications, and systems without exposing the business to unnecessary risks. Across industries, the advantages remain consistent: improved compliance, enhanced visibility, and stronger data protection. Whether in healthcare, finance, legal, or retail, secure workspaces ensure that sensitive information is protected without slowing down operations.“Secure workspace solutions are no longer optional—they are essential for modern organizations that want to grow securely,” said Matt Rosenthal, CEO and President of Mindcore Technologies. “Our mission is to deliver platforms that combine security, compliance, and productivity across industries.”

October 01, 2025 | Business Environment

Trualta Launches Caregiving & Work Toolkit for Employee Wellness

Trualta, the leading learning, support, and community-building platform for caregivers, has unveiled its Balancing Caregiving and Work Toolkit as part of its official expansion into the employee wellness and benefits market. Designed for today's workforce, the toolkit provides meaningful support to employees managing the dual demands of career and caregiving—a challenge faced by 63 million workers nationwide. Nearly 1 in 4 U.S. workers now provides unpaid care to a loved one, often juggling medical appointments, household tasks, and emotional strain on top of professional obligations. Left unsupported, working caregivers face higher risks of stress, burnout, and lost productivity. Trualta's new toolkit is designed to close this gap by giving employees evidence-informed, practical tools that promote resilience and balance. The Balancing Caregiving and Work Toolkit features 17 engaging learning activities across three key areas: Workplace Challenges: How to navigate benefits, legal protections, and employer conversations. Finding Balance: Tools for addressing guilt, burnout, and the "never enough" mindset, plus strategies for self-care and support networks. Strategies for Daily Life: Time management, boundary-setting, tech tools, and templates for care coordination. Delivered through flexible formats—articles, videos, worksheets, and real-life scenarios—the toolkit provides caregivers with actionable, emotionally grounded resources they can use right away. "Employers are waking up to the fact that caregiving is a workforce issue, not just a personal one," said Jonathan Davis, Founder of Trualta. "By offering practical, empathetic support, organizations can reduce turnover, increase productivity, and create a culture where caregivers feel valued—not stretched beyond their limits."

October 01, 2025 | Business Environment

Bionique Testing Labs Marks Growth with Facility Expansion Opening

Bionique Testing Laboratories LLC (Bionique), a subsidiary of Asahi Kasei and a globally recognized mycoplasma testing services specialist for the life science industry, hosted a Grand Opening Ceremony to commemorate the completion of its newly expanded facility. "This facility investment is about an expanded service offering," said Gladis Zamparo, CEO at Bionique. "For decades, customers have trusted Bionique for critical lot-release testing. Our expansion ensures we broaden our capabilities and digital experience, while maintaining accelerated turnaround times—so our partners can release safe products faster. " The new footprint features purpose-built labs designed for mycoplasma, sterility, endotoxin, and viral testing method development and processing. It also includes flexible containment labs and BSL capabilities to meet diverse modality needs across biologics, cell and gene therapies, and advanced therapeutics. The expansion increases capacity for high-volume, CGMP-compliant lot-release workflows with optimized sample logistics and throughput. "The industry is at a turning point," said Lori Daane, PhD., Chief Scientific Officer. "As global regulations evolve to enable broader adoption of rapid testing methods for mycoplasma and sterility, Bionique's decades of scientific rigor, method development, and quality systems provide a clear path to implementation, without compromising compliance." As announced in April this year, Bionique remains part of Asahi Kasei's Bioprocess division, which is now under the Asahi Kasei Life Science umbrella. Since 2021, Bionique and ViruSure, a Vienna-based CRO specializing in viral services, have joined forces to provide a comprehensive biosafety service offering. "This expansion allows Bionique to broaden its analytical portfolio, aligning with Asahi Kasei's strategy to invest in solutions for the life science industry with long-term growth potential," said Andy Bailey, CEO of ViruSure and Head of the Biosafety Testing Division at Asahi Kasei Bioprocess. "By building on Bionique's expertise in microbiological testing as well as ViruSure's expertise in virus safety testing of both traditional and novel therapeutic modalities, we aim to support customers on a global scale, advancing the safety and reliability of biopharmaceutical products across modalities and creating value for our partners and stakeholders."

September 29, 2025 | Business Environment

Eli Lilly Launches San Diego Gateway Labs to Drive Biotech Innovation and Collaboration

Eli Lilly and Company announced the official opening of its newest Lilly Gateway Labs (LGL) site in San Diego, California, expanding its network of shared innovation hubs designed to support early-stage biotechnology companies by providing lab space and opportunities to collaborate with Lilly scientists. The new facility, developed by and operated in partnership with Alexandria Real Estate Equities, Inc., is located on the One Alexandria Square Megacampus in Torrey Pines. LGL San Diego features 82,514 square feet of flexibly designed laboratory and office space to accommodate up to 15 life sciences companies and more than 250 employees of LGL-based companies. "At Lilly, we are committed to meeting the biotech ecosystem on its own terms, supporting companies at every stage and evolving alongside them," said Daniel Skovronsky, M.D., Ph.D., chief scientific officer, and president, Lilly Research Laboratories and Lilly Immunology. "The future of medicine depends on combining the strengths of academia, biotech and large pharma to solve some of the most difficult diseases facing patients. Our expanded presence here enables us to further connect with San Diego's vibrant startup community, world-leading scientists, and research institutions. Through collaborative spaces like Lilly Gateway Labs, we're enabling bold science to thrive." Lilly Gateway Labs offers startups access to wet lab facilities along with tailored scientific engagement and strategic guidance to help navigate the complexities of drug discovery and development. The model is designed to accelerate progress towards key milestones by combining infrastructure with deep expertise. LGL San Diego is Lilly's fourth U.S. Gateway Labs site, joining two locations in South San Francisco and one in Boston. The model is also expanding globally, with a newly opened LGL site in Beijing. Since the first Gateway Labs site opened in 2019, LGL-based companies have raised more than $2 billion in capital, supporting the development of 50+ therapeutics and platforms now in progress. "Our Lilly Gateway Labs model is working. We've seen sustained growth by staying true to our high-touch partnership approach. We start every engagement by asking how we can help. That mindset drives everything we do, from activating the Lilly network to provide scientific input to offering timely strategic counsel that helps founders avoid common pitfalls," said Julie Gilmore, Ph.D., vice president, and global head of Lilly Gateway Labs and Catalyze360 Portfolio Management. "As we expand in innovation centers such as San Diego, we're continuing our focus on scaling sustainably while preserving a hands-on approach that makes a meaningful difference for our partners."

September 24, 2025 | Business Environment

Catalent Opens New Global Headquarters in Tampa, Driving Growth

Catalent, Inc., the leader in enabling the development and supply of better treatments for patients worldwide, announced the opening of its new global corporate headquarters in Tampa, Fla. The state-of-the-art site has been designed to showcase innovation, collaboration and excellence, supporting the Company’s commitment to driving value for its pharmaceutical, biotech and consumer health customers through unparalleled service excellence and a Patient First mindset. “The opening of our new global headquarters in Tampa is an important milestone that reflects our aspirations for continued growth and recognizes our heritage as an organization built on innovation, service excellence and integrity,” said Alessandro Maselli, President & Chief Executive Officer of Catalent. “For nearly half a century, we have enjoyed a presence in the Tampa region where today we provide services ranging from early phase development to full-scale commercial manufacturing at our St. Petersburg site. We are excited to expand our presence in the region.”

September 23, 2025 | Business Environment

Trinity Capital Invests $45M in Rapid Micro Biosystems to Boost Life Sciences Growth

Trinity Capital Inc. a leading alternative asset manager, announced the commitment of $45 million in growth capital to Rapid Micro Biosystems , an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products. Rapid Micro specializes in automating microbial quality control in mission-critical applications such as environmental monitoring, water testing, sterility testing, and bioburden testing. The Company's Growth Direct® platform provides faster results, greater accuracy, increased operational efficiency, and stronger data integrity, enabling customers to make quicker decisions that help ensure a safe and consistent supply of important healthcare products. "In an industry where quality cannot be compromised, Rapid Micro Biosystems is delivering the automation and dependability manufacturers need," said Rob Lake, Senior Managing Director of Life Sciences at Trinity Capital. "They are transforming a critical process within biopharma manufacturing, and we are proud to partner with a team driving meaningful impact across the industry." This new capital will help scale Rapid Micro's operations, to include supporting the continued global commercial expansion of the Growth Direct platform, and ongoing investments to drive gross margin expansion through product cost reduction, increased manufacturing efficiencies, and service productivity. "We are pleased to partner with Trinity Capital, who shares our vision of automating manual microbial quality control testing methods used in biopharma manufacturing," said Robert Spignesi, President and CEO of Rapid Micro Biosystems. "This facility significantly strengthens our financial position and supports our continued focus on long-term revenue growth, margin expansion, and increasing shareholder value."

September 22, 2025 | Business Environment

Kindeva Launches UK Facility for Next-Gen Drug Delivery

Kindeva, a global CDMO and drug delivery expert, has officially opened its new UK headquarters at Charnwood Campus Science Innovation and Technology Park, Loughborough. The facility represents a significant expansion in Kindeva’s MDI services and will develop and test next-generation propellants (NGP) as the industry prepares to move to more environmentally friendly products. Nestled in the heart of Loughborough’s Technology Park, the 150,000 sq. ft. site offers a range of services across drug development, from early-stage viability, analytical method development, to commercial analysis. Boasting a Chemistry, Manufacturing and Controls (CMC) strategy and regulatory department to guide customers through complex compliance hurdles, the facility will support customers at every stage of the drug development journey. The official opening will be marked with a launch event hosted by the CEO of Kindeva, Milton Boyer and David Northage, Mayor of Charnwood. A ribbon-cutting ceremony will be followed by a site tour, where Kindeva will unveil its investment and recruitment strategy for the future. Commenting on the new site, Milton Boyer said: “The opening of our Loughborough Headquarters marks a significant milestone in Kindeva’s growth strategy as we continue to innovate, scale, and expand our global footprint.” The Loughborough HQ will be responsible for developing and analysing NGPs as the industry faces significant legislation aimed at reducing the environmental impact of the propellants currently used in pressurized metered-dose inhalers (pMDIs). Boyer continued: “Research estimates that inhalers contribute to 0.03% of total global greenhouse gas emissions, and represent 3% of the U.K. National Health Service (NHS) carbon footprint. Investment in our Loughborough site, new technologies and people, will allow Kindeva to become the leading force in the industry for sustainability and assuring supply continuity as the industry transitions to low Global Warming Potential (GWP) propellants.”

September 19, 2025 | Business Environment

Aurora Cannabis Strengthens EU Supply Chain with Leuna Facility Investment

Aurora Cannabis Inc, the Canadian-based leading global medical cannabis company, announces an investment over five years into operational upgrades at its EU-GMP manufacturing facility in Leuna, Germany. Building on best practices proven at Aurora's Canadian facilities, these improvements will increase flower growth capacity, product quality and drive cost efficiency. "This investment marks a significant milestone in our commitment to operational excellence and long-term growth in Europe," said Alex Miller, Executive Vice President of Operations, Science and Supply Chain at Aurora. "These upgrades will strengthen our supply chain resilience, expand our domestic capabilities in EU-GMP certified manufacturing, and position us to best meet the growing demand for high-quality medical cannabis in Europe with precision and efficiency." Aurora's global manufacturing network upholds the highest manufacturing standards that will be adopted at the German facility. With the goal of maximizing cultivation volume, the upgrades include commissioning additional grow rooms, new irrigation and lighting systems in existing rooms, and transitioning to hang dry and dry trim. As one of only three licensed cultivation facilities in the country, Aurora Leuna plays a pivotal role in supplying high-quality, locally grown medical cannabis to meet the needs of Germany's expanding patient base. Aurora Leuna currently grows cultivars under the IndiMed brand, and this expansion will enable the site to grow additional cultivars available from Aurora's leading genetics library. By continuously investing in operational capabilities, Aurora is best positioned to serve international markets at the highest standards.

Page 1 of 43

Featured Recruiters